Genetic investigations in childhood deafness

Postgraduate Medical Journal

Volumn 91, Issue 1077, 2015, Pages 395-402

  Parker, Michael ^a   Bitner Glindzicz, Maria ^b,c  

^a Western Bank   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TECTORIN; CONNEXIN 26; OTOFERLIN; PENDRIN; PEPTIDES AND PROTEINS; POTASSIUM CHANNEL KCNQ4; PROTEINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR POU3F4; TRANSMEMBRANE PROTEASE SERINE 3; UNCLASSIFIED DRUG;

AUTOSOMAL RECESSIVE INHERITANCE; BIOINFORMATICS; BRANCHIOOTORENAL SYNDROME; CHILD; CHILDHOOD DISEASE; DNA SEQUENCE; DOWN SYNDROME; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; HEALTH SURVEY; HEARING IMPAIRMENT; HUMAN; JERVELL AND LANGE-NIELSEN SYNDROME; MANDIBULOFACIAL DYSOSTOSIS; MOLECULAR DIAGNOSIS; NEXT GENERATION SEQUENCING; PHENOTYPE; REVIEW; USHER SYNDROME; VESTIBULAR DISORDER; VESTIBULOCOCHLEAR NERVE DISEASE; WAARDENBURG SYNDROME; WOLFRAM SYNDROME; WOLFRAM SYNDROME 1;

EID: 84937414354     PISSN: 00325473     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/postgradmedj-2014-306099rep     Document Type: Review

References (45)

1. Fortnum HM, Summerfield AQ, Marshall DH, et al. Prevalence of permanent childhood hearing impairment in the United Kingdom and implications for universal neonatal hearing screening: questionnaire based ascertainment study. BMJ 2001;323:536–40.
2. Pimperton H, Kennedy CR. The impact of early identification of permanent childhood hearing impairment on speech and language outcomes. Arch Dis Child 2012;97:648–53.
3. http://baap org uk/Resources/Documents,GuidelinesClinicalStandards aspx (accessed May 2014).
4. http://www.lmdatabases.com (accessed May 2014).
5. Licameli G, Kenna MA. Is computed tomography (CT) or magnetic resonance imaging (MRI) more useful in the evaluation of pediatric sensorineural hearing loss? Laryngoscope 2010;120:2358–9.
6. Haffey T, Fowler N, Anne S. Evaluation of unilateral sensorineural hearing loss in the pediatric patient. Int J Pediatr Otorhinolaryngol 2013;77:955–8.
7. http://hereditaryhearingloss.org (accessed May 2014).
8. Gasparini P, Rabionet R, Barbujani G, et al. High carrier frequency of the 35delG deafness mutation in European populations. Genetic Analysis Consortium of GJB2 35delG. Eur J Hum Genet 2000;8:19–23.
9. Pagarkar W, Bitner-Glindzicz M, Knight J, et al. Late postnatal onset of hearing loss due to GJB2 mutations. Int J Pediatr Otorhinolaryngol 2006;70:1119–24.
10. Norris VW, Arnos KS, Hanks WD, et al. Does universal newborn hearing screening identify all children with GJB2 (Connexin 26) deafness? Penetrance of GJB2 deafness. Ear Hear 2006;27:732–41.
11. Morell RJ, Kim HJ, Hood LJ, et al. Mutations in the connexin 26 gene (GJB2) among Ashkenazi Jews with nonsyndromic recessive deafness. N Engl J Med 1998;339:1500–5.
12. Kudo T, Ikeda K, Kure S, et al. Novel mutations in the connexin 26 gene (GJB2) responsible for childhood deafness in the Japanese population. Am J Med Genet 2000;90:141–5.
13. Abe S, Usami S, Shinkawa H, et al. Prevalent connexin 26 gene (GJB2) mutations in Japanese. J Med Genet 2000;37:41–3.
14. Common JE, Di WL, Davies D, et al. Further evidence for heterozygote advantage of GJB2 deafness mutations: a link with cell survival. J Med Genet 2004;41:573–5.
15. Snoeckx RL, Huygen PL, Feldmann D, et al. GJB2 mutations and degree of hearing loss: a multicenter study. Am J Hum Genet 2005;77:945–57.
16. Hall A, Pembrey M, Lutman M, et al. Prevalence and audiological features in carriers of GJB2 mutations, c.35delG and c.101T>C (p.M34T), in a UK population study. BMJ Open 2012;2:p 2: e001238.
17. Wattanasirichaigoon D, Limwongse C, Jariengprasert C, et al. High prevalence of V37I genetic variant in the connexin-26 (GJB2) gene among non-syndromic hearing-impaired and control Thai individuals. Clin Genet 2004;66:452–60.
18. Everett LA, Glaser B, Beck JC, et al. Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat Genet 1997;17:411–22.
19. Scott DA, Wang R, Kreman TM, et al. The Pendred syndrome gene encodes a chloride-iodide transport protein. Nat Genet 1999;21:440–3.
20. Usami S, Abe S, Weston MD, et al. Non-syndromic hearing loss associated with enlarged vestibular aqueduct is caused by PDS mutations. Hum Genet 1999;104:188–92.
21. Colvin IB, Beale T, Harrop-Griffiths K. Long-term follow-up of hearing loss in children and young adults with enlarged vestibular aqueducts: relationship to radiologic findings and Pendred syndrome diagnosis. Laryngoscope 2006;116:2027–36.
22. Luxon LM, Cohen M, Coffey RA, et al. Neuro-otological findings in Pendred syndrome. Int J Audiol 2003;42:82–8.
23. Norrix LW, Velenovsky DS. Auditory neuropathy spectrum disorder (ANSD): a review. J Speech Lang Hear Res 2014;57:1564–76.
24. Matsunaga T, Mutai H, Kunishima S, et al. A prevalent founder mutation and genotype-phenotype correlations of OTOF in Japanese patients with auditory neuropathy. Clin Genet 2012;82:425–32.
25. Varga R, Avenarius MR, Kelley PM, et al. OTOF mutations revealed by genetic analysis of hearing loss families including a potential temperature sensitive auditory neuropathy allele. J Med Genet 2006;43:576–81.
26. Schoen CJ, Emery SB, Thorne MC, et al. Increased activity of Diaphanous homolog 3 (DIAPH3)/diaphanous causes hearing defects in humans with auditory neuropathy and in Drosophila. Proc Natl Acad Sci USA 2010;107:13396–401.
27. Weegerink NJ, Schraders M, Oostrik J, et al. Genotype-phenotype correlation in DFNB8/10 families with TMPRSS3 mutations. J Assoc Res Otolaryngol 2011;12:753–66.
28. Shearer AE, Black-Ziegelbein EA, Hildebrand MS, et al. Advancing genetic testing for deafness with genomic technology. J Med Genet 2013;50:627–34.
29. Diaz-Horta O, Duman D, Foster J, et al. Whole-exome sequencing efficiently detects rare mutations in autosomal recessive nonsyndromic hearing loss. PLoS ONE 2012;7:e50628.
30. Brownstein Z, Friedman LM, Shahin H, et al. Targeted genomic capture and massively parallel sequencing to identify genes for hereditary hearing loss in Middle Eastern families. Genome Biol 2011;12:R89.
31. Hilgert N, Smith RJ, Van CG. Forty-six genes causing nonsyndromic hearing impairment: which ones should be analyzed in DNA diagnostics? Mutat Res 2009;681:189–96.
32. Bespalova IN, Van CG, Bom SJ, et al. Mutations in the Wolfram syndrome 1 gene (WFS1) are a common cause of low frequency sensorineural hearing loss. Hum Mol Genet 2001;10:2501–8.
33. Cryns K, Pfister M, Pennings RJ, et al. Mutations in the WFS1 gene that cause low-frequency sensorineural hearing loss are small non-inactivating mutations. Hum Genet 2002;110:389–94.
34. Rendtorff ND, Lodahl M, Boulahbel H, et al. Identification of p.A684V missense mutation in the WFS1 gene as a frequent cause of autosomal dominant optic atrophy and hearing impairment. Am J Med Genet A 2011;155A:1298–313.
35. Lalwani AK, Jackler RK, Sweetow RW, et al. Further characterization of the DFNA1 audiovestibular phenotype. Arch Otolaryngol Head Neck Surg 1998;124:699–702.
36. Hildebrand MS, Morin M, Meyer NC, et al. DFNA8/12 caused by TECTA mutations is the most identified subtype of nonsyndromic autosomal dominant hearing loss. Hum Mutat 2011;32:825–34.
37. Hildebrand MS, Tack D, McMordie SJ, et al. Audioprofile-directed screening identifies novel mutations in KCNQ4 causing hearing loss at the DFNA2 locus. Genet Med 2008;10:797–804.
38. Phelps PD, Reardon W, Pembrey M, et al. X-linked deafness, stapes gushers and a distinctive defect of the inner ear. Neuroradiology 1991;33:326–30.
39. Wang Q, Xue Y, Zhang Y, et al. Genetic basis of Y-linked hearing impairment. Am J Hum Genet 2013;92:301–6.
40. Bitner-Glindzicz M, Pembrey M, Duncan A, et al. Prevalence of mitochondrial 1555A-->G mutation in European children. N Engl J Med 2009;360:640–2.
41. Shearer AE, Deluca AP, Hildebrand MS, et al. Comprehensive genetic testing for hereditary hearing loss using massively parallel sequencing. Proc Natl Acad Sci USA 2010;107:21104–9.
42. Francey LJ, Conlin LK, Kadesch HE, et al. Genome-wide SNP genotyping identifies the Stereocilin (STRC) gene as a major contributor to pediatric bilateral sensorineural hearing impairment. Am J Med Genet A 2012;158A:298–308.
43. Eppsteiner RW, Shearer AE, Hildebrand MS, et al. Using the phenome and genome to improve genetic diagnosis for deafness. Otolaryngol Head Neck Surg 2012;147:975–7.
44. Rehman AU, Morell RJ, Belyantseva IA, et al. Targeted capture and next-generation sequencing identifies C9orf75, encoding taperin, as the mutated gene in nonsyndromic deafness DFNB 79. Am J Hum Genet 2010;86:378–88.
45. Li Y, Pohl E, Boulouiz R, et al. Mutations in TPRN cause a progressive form of autosomal-recessive nonsyndromic hearing loss. Am J Hum Genet 2010;86:479–84.